Clinical Trial: A Study of BL-M08D1 in Patients With Recurrent or Metastatic Gynecological Malignancies and Other Solid Tumors

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07793825) titled 'A Study of BL-M08D1 in Patients With Recurrent or Metastatic Gynecological Malignancies and Other Solid Tumors' on Aug. 26.

Brief Summary: This Phase Ib/II study is a clinical study to explore the efficacy and safety of BL-M08D1 for injection in patients with recurrent or metastatic gynecological tumors and other solid tumors.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Gynecological Tumors Solid Tumors

Intervention: DRUG: BL-M08D1

Administration by intravenous infusion for a cycle of 3 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

Disclaimer: Curated ...